Effect of prenatal exposure to fine particulate matter and intake of Paracetamol (Acetaminophen) in pregnancy on eczema occurrence in early childhood

Science of the Total Environment

Volumn 409, Issue 24, 2011, Pages 5205-5209

  Jedrychowski, Wieslaw ^a   Spengler, John D ^b   Maugeri, Umberto ^c   Miller, Rachel L ^d,e   Budzyn Mrozek, Dorota ^a   Perzanowski, Matt ^d,e   Flak, Elzbieta ^a   Mroz, Elzbieta ^a   Majewska, Renata ^a   Kaim, Irena ^a   Perera, Frederica ^d  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Institute for Clinical Medicine and Rehabilitation   (Italy)

^d Columbia University ^*  (United States)

^e Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Birth cohort study; Early childhood; Eczema; Fine particulate matter; Paracetamol; Pregnancy

Indexed keywords

COHORT STUDIES; EARLY CHILDHOOD; ECZEMA; FINE PARTICULATE MATTER; PARACETAMOL; PREGNANCY;

HEALTH RISKS; POISSON DISTRIBUTION; POPULATION STATISTICS; REGRESSION ANALYSIS; RISK PERCEPTION;

OBSTETRICS;

PARACETAMOL;

ALLERGY; CHILD HEALTH; COHORT ANALYSIS; DISEASE PREVALENCE; DRUG; HEALTH RISK; HYPOTHESIS TESTING; PARTICULATE MATTER; POLLUTION EXPOSURE; PREGNANCY; PUBLIC HEALTH; SKIN DISORDER;

ADULT; AIR POLLUTANT; ARTICLE; COHORT ANALYSIS; DRUG DOSE REGIMEN; ECZEMA; FEMALE; FOLLOW UP; HOME ENVIRONMENT; HUMAN; INCIDENCE; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEWBORN; PARTICULATE MATTER; PREGNANCY; PRENATAL DRUG EXPOSURE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SIBLING;

ACETAMINOPHEN; ADULT; AIR POLLUTANTS; ANALGESICS, NON-NARCOTIC; CHILD; COHORT STUDIES; ECZEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; ODDS RATIO; PARTICULATE MATTER; POLAND; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

CRACOW; MALOPOLSKIE; POLAND;

EID: 80054778566     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2011.08.068     Document Type: Article

References (47)

1. Amberbir A., Medhin G., Alem A., Britton J., Davey G., Venn A. The role of acetaminophen and geohelminth infection on the incidence of wheeze and eczema: a longitudinal birth cohort study. Am J Respir Crit Care Med 2011, 183:165-170.
2. Asher M.I., Montefort S., Björkstèn B., Lai C.K., Strachan D.P., Weiland S.K., et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeated multicountry cross-sectional surveys. Lancet 2006, 368:733-743.
3. Barr R.G., Wentowski C.C., Curhan G.C., Somers S.C., Stampfer M.J., Schwartz J., et al. Prospective study of acetaminophen use and newly diagnosed asthma among women. Am J Respir Crit Care Med 2004, 169:836-841.
4. Beasley R., Clayton T.O., Crane J., Lai C.K., Montefort S.R., Mutius E., et al. Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents. International Study of Asthma and Allergies in Childhood Phase Three. Am J Respir Crit Care Med 2011, 183:171-178.
5. Beasley R., Clayton T.O., Crane J., von Mutius E., Lai C.K., Montefort S., et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7years: analysis from phase three of the ISAAC program. Lancet 2008, 372:1039-1048.
6. Belyhun Y., Amberbir A., Medhin G., Erko B., Hanlon C., Venn A., et al. Prevalence and risk factors of wheeze and eczema in 1-year-old children: the Butajira birth cohort, Ethiopia. Clin Exp Allergy 2010, 40:619-626.
7. Bergmann R.L., Edenharter G., Bergmann K.E., Forster J., Bauer C.P., Wahn V., et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998, 28:965-970.
8. Bisgaard H., Halkjaer L.B., Hinge R., Giwercman C., Palmer C., Silveira L., et al. Risk analysis of early childhood eczema. J Allergy Clin Immunol 2009, 123:1355-1360.
9. Businco L., Falconieri P., Di Rienzo A., Bruno G. From atopic dermatitis to asthma: the risk factors and preventive measures. Pediatr Pulmonol Suppl 1997, 16:19-20.
10. Chen T.S., Richie J.P., Lang C.A. Life span profiles of glutathione and acetaminophen detoxification. Drug Metab Dispos 1990, 18:882-887.
11. Cohet C., Cheng S., MacDonald C., Baker M., Foliaki S., Huntington N., et al. Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood. J Epidemiol Community Health 2004, 58:852-857.
12. Devalia J.L., Rusznak C., Wang J., Khair O.A., Abdelaziz M., Calderon M.A., et al. Air pollutants and respiratory hypersensitivity. Toxicol Lett 1996, 86:169-176.
13. Dimova S., Hoet P.H.M., Dinsdale D., Nemery B. Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. Int J Biochem Cell Biol 2005, 37:1727-1737.
14. Dimova S., Hoet P.H.M., Nemery B. Paracetamol (acetaminophen) cytotoxicity in rat type II pneumocytes and alveolar macrophages in vitro. Biochem Pharmacol 2000, 59:1467-1475.
15. Forrest J.A.H., Clements J.A., Prescott L.F. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet 1982, 7:93-107.
16. Garcia-Marcos L., Gonzalez-Diaz C., Garvajal-Uruena I., Pac-Sa M.R., Busquets-Monge R.M., Suárez-Varela M.M., et al. Early exposure to paracetamol or to antibiotics and eczema at school age: modification by asthma and rhinoconjunctivitis. Pediatr Allergy Immunol 2010, 21:1036-1042.
17. Garcia-Marcos L., Sanchez_Solis M., Perez-Fernandez V. Early exposure to acetaminophen and allergic disorders. Curr Opin Allergy Clin Immunol 2011, 11:162-173.
18. Garcia-Marcos L., Sanchez-Solis M., Perez-Fernandez V., Pastor-Vivero M.D., Mondejar-Lopez P., Valverde-Molina J. Is the effect of prenatal Paracetamol exposure on preschool wheezing modified by asthma in the mother?. Int Arch Allergy Immunol 2008, 149:33-37.
19. Heinrich J., Hoelscher B., Wjst M., Ritz B., Cyrys J., Wichmann H. Respiratory diseases and allergies in two polluted areas in East Germany. Environ Health Perspect 1999, 107:53-62.
20. Heinrich J., Slama R. Fine particles, a major threat to children. Int J Hyg Environ Health 2007, 210:617-622.
21. Illi S., von Mutius E., Lau S., Nickel R., Grüber C., Niggemann B., et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 2004, 113:925-931.
22. Kay J., Gawkrodger D.J., Mortimer M.J., Jaron A.G. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994, 30:35-39.
23. Koniman R., Chan Y.H., Tan T.N., Van Bever H.P. A matched patient-sibling study on the usage of Paracetamol and the subsequent development of allergy and asthma. Pediatr Allergy Immunol 2007, 18:128-134.
24. Krämer U., Suguri D., Ranft U., Krutmann J., von Berg A., Berdel D., et al. Eczema, respiratory allergies, and traffic-related air pollution in birth cohorts from small-town areas. J Dermatol Sci 2009, 56:99-105.
25. Li N., Hao M., Phalen R.F., Hinds W.C., Nel A.E. Particulate air pollutants and asthma. A paradigm for the role of the oxidative stress in PM-induced adverse health effects. Clin Immunol 2003, 109:250-265.
26. Lowe A.J., Carlin J.B., Bennet C.M., Hosking C.S., Allen K.J., Robertson C.F., et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ 2010, 341:e4616.
27. Mazzoli-Rocha F., Fernandes S., Einicker-Lamas M., Aranjo-Zin W. Roles of oxidative stress in signaling and inflammation induced by particulate matter. Cell Biol Toxicol 2010, 26:481-498.
28. McKeever T.M., Lewis S.A., Smit H.A., Burney P., Britton J.R., Cassano P.A. The effect of acetaminophen, aspirin, and ibuprofen on respiratory disease and lung function. Am J Respir Crit Care Med 2005, 171:966-971.
29. Micheli L., Cerretani D., Fiaschi A.I., Giorgi G., Romeo M.R., Runci F.M. Effect of acetaminophen on glutathione levels in rat testis and lung. Environ Health Perspect 1994, 102(Suppl 9):63-64.
30. Morcillo E.J., Estrela J., Cortijo J. Oxidative stress and pulmonary inflammation: pharmacological intervention with antioxidants. Pharmacol Res 1999, 40:393-404.
31. Newson R.B., Shaheen S.O., Chinn S., Burney P.G. Paracetamol sales and atopic disease in children and adults: an ecological analysis. Eur Resp J 2000, 16:817-823.
32. Nuttall S.L., Khan J.N., Thorpe G.H., Langford N., Kendall M.J. The impact of therapeutic doses of paracetamol on serum total antioxidant capacity. J Clin Pharmacol Ther 2003, 28:289-294.
33. Persky V., Piorkowski J., Hermandez E., Chavez N., Wagner-Cassanova C., Vergara C., et al. Prenatal exposure to acetaminophen and respiratory symptoms in the first year of life. Ann Allergy Asthma Immunol 2008, 101:271-278.
34. Perzanowski M.S., Miller R.L., Tang D., Ali D., Garfinkel R.S., Chew G.L., et al. Prenatal acetaminophen exposure and risk of wheeze at age 5years in an urban, low income cohort. Thorax 2010, 65:118-123.
35. Peterson J.D., Herzenberg L.A., Vasquez K., Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci U S A 1998, 95:3071-3076.
36. Prescott L.F. Kinetics and metabolism of paracetamol and phenacetin. Brit J Clin Pharmacol 1980, 10:291S-298S.
37. Rebordosa C., Kogevinas M., Sorensen H.T., Olsen J. Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: a birth cohort study. Int J Epidemiol 2008, 37:583-590.
38. Ruszniak C., Jemkins S., Mills P.R., Sapsford R.J., Devaglia J.L., Davies R.J. Mechanism of pollution-induced allergy and asthma. Rev Fr Allergol 1998, 38:S80-S90.
39. Schwarze P.E., Ovrevik J., Lag M., Refsnes M., Nafstad P., Hetland R.B., et al. Particulate matter proprieties and health effects: consistency of epidemiological and toxicological studies. Human Exp Toxicol 2006, 25:559-579.
40. Shaheen S.O., Newson R.B., Henderson A.J., Headley J.E., Stratton F.D., Jones R.W., et al. Prenatal paracetamol exposure and risk of asthma and elevated immunoglobulin E in childhood. Clin Exp Allergy 2005, 35:18-25.
41. Shaheen S.O., Newson R.B., Sherriff A., Henderson A.J., Heron J.E., Burney P.G., et al. Paracetamol use in pregnancy and wheezing in early childhood. Thorax 2002, 57:958-963.
42. Shaheen S.O., Sterne J.A., Songhurst C.E., Burney P.G. Frequent paracetamol use and asthma in adults. Thorax 2000, 55:266-270.
43. Spergel J.M., Paller A.S. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003, 112(6 Suppl):S118-S127.
44. Strachan D.P. Time trends in asthma and allergy: ten questions, fewer answers. Clin Exp Allergy 1995, 25:791-794.
45. van der Hulst A.E., Klip H., Brand P.L. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 2007, 120:565-569.
46. Wadonda-Kabondo N., Sterne J.A., Golding J., Kennedy C.T., Archer C.B., Dunnill M.G., et al. A prospective study of the prevalence and incidence of atopic dermatitis in children aged 0-42 months. Br J Dermatol 2003, 149:1023-1028.
47. Williams H.C. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000, 25:522-529.